Andrew
Singh
a,
Andrew
Lofts
a,
Ramya
Krishnan
b,
Matthew
Campea
a,
Lan
Chen
b,
Yonghong
Wan
b and
Todd
Hoare
*a
aDepartment of Chemical Engineering, McMaster University, 1280 Main St. W., Hamilton, Ontario L8S 4L7, Canada. E-mail: hoaretr@mcmaster.ca
bDepartment of Pathology and Molecular Medicine, McMaster University, 1280 Main St. W., Hamilton, Ontario L8S 4L7, Canada
First published on 15th April 2024
Comb copolymer analogues of poly(lactic acid)-polyethylene glycol block copolymers (PLA-b-PEG) offer potential to overcome the inherent chemistry and stability limitations of their linear block copolymer counterparts. Herein, we examine the differences between P(L)LA10K-b-PEG10K and linear-comb copolymer analogues thereof in which the linear PEG block is replaced by poly(oligo(ethylene glycol) methacrylate) (POEGMA) blocks with different side chain (comb) lengths but the same overall molecular weight. P(L)LA10K-b-POEGMA47510K and P(L)LA10K-b-POEGMA200010K block copolymers were synthesized via activators regenerated by electron transfer atom transfer radical polymerization (ARGET ATRP) and fabricated into self-assembled nanoparticles using flash nanoprecipitation via confined impinging jet mixing. Linear-comb copolymer analogues based on PLA-b-POEGMA yielded smaller but still well-controlled nanoparticle sizes (88 ± 2 nm and 114 ± 1 nm respectively compared to 159 ± 2 nm for P(L)LA10K-b-PEG10K nanoparticles) that exhibited improved colloidal stability relative to linear copolymer-based nanoparticles over a 15 day incubation period while maintaining comparably high cytocompatibility, although the comb copolymer analogues had somewhat lower loading capacity for doxorubicin hydrochloride. Cell spheroid studies showed that the linear-comb copolymers promoted enhanced tumor transport and thus cell killing compared to conventional linear block copolymers. In vivo studies showed all NP types could passively accumulate within implanted CT26 tumors but with different accumulation profiles, with P(L)LA10K-b-POEGMA200010K NPs showing continuous accumulation throughout the full 24 h monitoring period whereas tumor accumulation of P(L)LA10K-b-POEGMA47510K NPs was significant only between 8 h and 24 h. Overall, the linear-comb copolymer analogues exhibited superior stability, biodistribution, spheroid penetration, and inherent tunability over linear NP counterparts.
Among the many amphiphilic block copolymers assessed for their potential for drug delivery, copolymers consisting of the water soluble polymer poly(ethylene glycol) (PEG) and a water-insoluble degradable polyester (e.g. poly(lactide) – PLA, poly(lactide-co-glycolic acid) – PLGA, or poly(caprolactone) – PCL) are the most widely investigated.4,10,11 The hydrophobic polyester enables self-assembly of the block copolymers into NPs in water, while the choice of polyester governs the hydrolytic half life and thus the degradation time/stability of the nanoparticle.12 PLA is particularly widely used in biomedical applications due to it being relatively inexpensive, produced from renewable resources, possessing low immunogenicity, and being biodegradable under physiologically relevant conditions into a common metabolic by-product (lactic acid).13 Complementarily, the PEG hydrophilic block creates a hydrophilic interface for the NPs, reducing their detection by the immune system, typically increasing circulation times, as well as imparting favorable dispersibility in physiological media.14–16 These benefits have led PEGylated NPs to be of interest in applications including biosensing, bioimaging, chemotherapy, and tissue engineering.17 Specific to drug delivery, both PEG and PLA copolymers are approved for in vivo use in multiple jurisdictions, with block copolymers thereof explored for the delivery of proteins, genes, photosensitizers, small molecules, and other therapeutics for ophthalmic, vaginal, oral, chemotherapeutic, and other drug delivery applications.4,18–21 Chemotherapeutic applications of such NPs have attracted particular interest given that the size range and surface chemistry achievable with self-assembled NPs can overcome many of the multiple physiological barriers toward drug transport to tumors by exploiting their potential to evade immune detection14 and penetrate through trans-endothelial pathways and ultimately into cancer cells.22 However, PEG-based block copolymers also pose several limitations for the rational engineering of drug delivery NPs in terms of their chain-end only functionalization, limiting the degree to which a PEG-based interface can be altered to customize delivery pathways. In addition, reports of the presence of PEG antibodies (estimated to be present in as many as 72% of the population23,24) may offer an additional limitation to the wide-spread use of PEG-based materials in drug formulation, although the existence and ultimate importance of PEG antibodies remains a point of debate in the literature.
As an alternative to PEG, amphiphilic brush or comb block copolymers have recently been explored that can retain many of the beneficial properties of linear PEG while providing a significant additional level of chemical and interfacial tunability. Poly(oligoethylene glycol methacrylate) (POEGMA) is one such comb PEG derivative that has a suite of attractive properties including: (1) facile modification of interfacial properties by the length of the oligo(ethylene glycol) side chains, enabling responses ranging from thermoresponsive behavior at short side chain lengths to highly protein-repellent behavior at longer side chain lengths;25–27 (2) tunable PEG densities depending on the mixture of OEGMA side chain length comonomers used;27 and (3) facile polymerization via free radical or controlled free radical techniques, enabling a broad range of potential functionalization within the combs themselves (instead of only at the chain ends) via judicious selection of functional comonomers that are also amenable to free radical polymerization. In particular, controlled radical polymerization techniques such as reversible addition–fragmentation chain-transfer (RAFT) and atom transfer radical polymerization (ATRP) have both been noted to enable POEGMA polymerization, with ATRP in particular leveraged to create well-defined POEGMA-based copolymers with tunable molecular weights and side chain lengths/functionalization.27 Such controlled/living radical polymerization techniques bypass many of the challenges associated with fabricating comb copolymers (e.g. steric bulk at graft from/to sites that results in irregular comb densities or inconsistent molecular weight growth) that can result in low degrees of polymerization and high polydispersities in other types of comb polymers,28 thus enabling a systematic study of how the architecture of the combs influences drug delivery characteristics (akin to previous studies on graft PEGylated polymers29,30) using a more scalable and direct polymerization strategy. The commercial availability of OEGMA monomers with different side chain lengths also facilitates the fabrication of comb polymers compared to other reported techniques in which a secondary grafting step typically must be performed after the initial polymerization reaction, offering a key translational advantage relative to other reported comb polymer-based nanoparticle vehicles. Furthermore, although the mechanism remains unclear, POEGMA has been reported to avoid PEG-related immunogenicity,31 potentially related to the steric crowding around each oligo(ethylene glycol) side chain that may inhibit immune cell recognition. As such, POEGMA is a viable alternative to PEG in multiple applications but specifically of interest in biological applications in which circulation time is vital.
Herein, we directly compare the physical properties and in vivo tumor model biodistribution properties of NPs self-assembled from block copolymers with the same molecular weight and same relative hydrophobic/hydrophilic block lengths fabricated using PLA as the hydrophobic block and one of three hydrophilic blocks: linear PEG (P(L)LA10K-b-PEG10K), POEGMA with n = 8–9 ethylene oxide repeat units in the side chains (P(L)LA10K-b-POEGMA47510K) and POEGMA with n = 40 ethylene oxide repeat units in the side chains (P(L)LA10K-b-POEGMA200010K). The equivalent molecular weight of each of the three block copolymers synthesized, both within each block as well as overall, enables a direct assessment of the effect of the comb architecture (i.e. the number of side-chains versus side-chain length) of linear-comb copolymers on properties relevant to nanoparticle-based drug delivery including particle size, particle stability, anti-cancer drug encapsulation efficiency, cytocompatibility, and biodistribution in a mouse tumor model. We demonstrate that the comb copolymers offer the potential for lower sizes, improved stability, prolonged circulation times, enhanced spheroid penetration and thus killing, and improved tumour localization without compromising cytocompatibility, albeit at the cost of drug loading capacity.
![]() | ||
Scheme 1 General synthesis of P(L)LA-b-POEGMA (top) and Cy5-labelled P(L)LA-b-POEGMA (bottom) via ARGET ATRP. |
Table 1 summarizes the molecular weight properties of the block copolymers produced as well as corresponding information for the commercial P(L)LA-PEG polymer used as the linear polymer control (see ESI, Fig. S4–S6† for full traces). Both POEGMA-based blocks had number average molecular weights (Mn) of ∼10 kDa as measured via gel permeation chromatography, comparable to the 10 kDa macroinitiator used and the 10 kDa PEG chain present on the P(L)LA-PEG commercial polymer. As such, all three polymers tested have an equivalent hydrodynamic radius, a parameter we anticipate to be most predictive of nanoparticle assembly (given its direct correlation with polymer geometry) and thus chosen for use as the basis for direct comparisons between the samples. 1H NMR analysis was also conducted to calculate the Mn by comparing the relative amounts of both lactic acid and ethylene oxide repeat units incorporated into the polymer (see ESI Fig. S5 and S6 and Table S1†). Based on the known 10 kDa molecular weight of the PLA macroinitiator, the Mn values of the POEGMA blocks for P(L)LA10K-b-POEGMA47510K and P(L)LA10K-b-POEGMA200010K were both calculated to be ∼45 kDa, significantly higher than the GPC result and consistent with the compact comb structure of the OEGMA-based blocks resulting in lower effective hydrodynamic diameters at equivalent molecular weights. Of note, the equivalent measured hydrodynamic diameters and molecular weights of the two P(L)LA-b-POEGMA polymers facilitate highly relevant direct comparisons between those samples. Đ values of the synthesized polymers were also found to be consistently low (<1.1), indicative of tight control over the polymerization process using the ARGET ATRP protocol. Based on the equivalent hydrodynamic diameters of both the P(L)LA and PEG-based blocks among all three copolymers, the effects of comb length can be assessed independent of the effects of block length in subsequent experiments.
Polymer | M n (GPC) | M n (1H NMR) | M w (GPC) | Đ (GPC) |
---|---|---|---|---|
2-Bromoisobutyryl terminated poly(L-lactide) macroinitiator | 10![]() |
7600 | — | <1.10 |
P(L)LA10K-b-PEG10K | 19![]() |
19![]() |
23![]() |
1.18 |
P(L)LA10K-b-POEGMA47510K | 19![]() |
53![]() |
20![]() |
1.06 |
P(L)LA10K-b-POEGMA200010K | 19![]() |
53![]() |
21![]() |
1.08 |
NPs were then fabricated via flash nanoprecipitation based on each of the linear and comb copolymers fabricated using a CIJ-M device. Each of the linear-comb copolymers maintains a critical micelle concentration (CMC) < 40 mg L−1 to ensure facile nanoassembly (ESI Fig. S1†), although the longer comb (and thus sterically bulkier) P(L)LA10K-b-POEGMA200010K polymer CMC is significantly higher than that of the shorter comb P(L)LA10K-b-POEGMA47510K polymer or the linear–linear P(L)LA10K-b-PEG10K polymer. Flash nanoprecipitation facilitates the production of NPs within or very close to the targeted circulation size range of ∼100–150 nm for each of the three block copolymers (Table 2), with TEM images showing that all NPs showed spherical morphologies (Fig. 1A–C). However, NPs fabricated from the linear-comb analogues were both initially smaller (particularly those prepared with the shorter n = 8–9 side chains), exhibit lower polydispersity, and better maintained their size over extended incubation at 37 °C in a PBS solution to emulate physiological conditions compared to the linear–linear P(L)LA10K-b-PEG10K copolymer (Fig. 1D and E). Changing the solvent from THF to DMF significantly reduced NP size for the linear-comb copolymer NPs by a factor of up to ∼2 for the P(L)LA10K-b-POEGMA47510K NPs but had little impact on the size of the linear–linear copolymer NPs; the very high solubility of the POEGMA475 block in DMF can be correlated directly to this result, with the longer PEG linear chain or the longer comb length POEGMA2000 exhibiting still sufficient but somewhat lower solubility. Correspondingly, the P(L)LA10K-b-POEGMA47510K NPs fabricated in DMF retained high colloidal stability over at least two weeks (Fig. 1E) without significant alterations in the observed particle size distribution (ESI Fig. S7†) while NPs prepared with both the POEGMA2000 and PEG hydrophilic blocks using DMF showed reduced stability relative to their THF-fabricated counterparts consistent with the potential for trace amounts of DMF to drive block copolymer rearrangements/disassembly in suspension. The very low particle size achievable with the shorter comb P(L)LA10K-b-POEGMA47510K copolymers in DMF is notable for a rapid nanoparticle fabrication method such as flash nanoprecipitation.35
Solvent | Polymer | Hydrodynamic diameter (nm) | Polydispersity | Zeta potential (mV) | Drug loading capacity (%) | Encapsulation efficiency (%) |
---|---|---|---|---|---|---|
THF | P(L)LA10K-b-PEG10K | 159 ± 2 | 0.34 | −4 ± 1 | — | — |
P(L)LA10K-b-POEGMA47510K | 88 ± 2 | 0.27 | −15 ± 2 | — | — | |
P(L)LA10K-b-POEGMA200010K | 114 ± 1 | 0.21 | −11 ± 1 | — | — | |
DMF | P(L)LA10K-b-PEG10K | 151 ± 1 | 0.29 | −1 ± 1 | — | — |
P(L)LA10K-b-POEGMA47510K | 43 ± 1 | 0.28 | −1 ± 1 | — | — | |
P(L)LA10K-b-POEGMA200010K | 81 ± 3 | 0.39 | −1 ± 1 | — | — | |
DMF + 1 mg mL−1 Dox·HCl) | P(L)LA10K-b-PEG10K | 343 ± 3 | 0.25 | 1 ± 2 | 3.3 ± 0.1 | 33 ± 1 |
P(L)LA10K-b-POEGMA47510K | 97 ± 3 | 0.33 | 1 ± 4 | 2.5 ± 0.1 | 25 ± 1 | |
P(L)LA10K-b-POEGMA200010K | 102 ± 5 | 0.37 | 1 ± 1 | 1.4 ± 0.2 | 14 ± 2 |
To assess the effect of the PEG block morphology on drug loading, DMF was selected to as the solvent phase during flash nanoprecipitation to facilitate the solubilization of doxorubicin hydrochloride in the precursor organic solution. Both encapsulation efficiency (EE) and drug loading capacity (DLC) are reduced by the introduction of a comb morphology in the PEG block (Table 2), with only minimal reductions observed for the shorter POEGMA475 hydrophilic block (n = 8–9 side chains, ∼15% decrease) but significantly higher reductions observed with the longer POEGMA2000 hydrophilic block (n = 40 side chains, >50% decrease). As such, while the introduction of a comb morphology in the PEG block reduces the particle size and improves the colloidal stability of the NPs, the concurrent reduction in drug loading capacity must also be considered depending on the required dose of therapeutic to be delivered. Of note, doxorubicin loading significantly increased the particle size of the linear–linear P(L)LA10K-b-PEG10K copolymer above the particle size range typically cited to enable long-term circulation (20–250 nm) while both comb copolymers exhibit only small increases in particle size that keep the loaded particle size of the NPs within the efficient circulation range (∼50–100 nm), suggesting another benefit of the comb copolymer building blocks.36–38
The cytotoxicity of each NP type was assessed by conducting a resazurin assay on 3T3 NIH mouse fibroblasts at concentration of up to 1 mg mL−1 for 24 hours. None of the NP formulations displayed significant cytotoxicity in vitro at any tested concentrations, using 80% cell viability as the threshold for toxicity (Fig. 2). As such, NPs based on both the linear and comb PEG block copolymers are non-cytotoxic to cells.
To assess the effect of the comb structure of the hydrophilic blocks on tumor transport, P(L)LA10K-b-POEGMA10K NPs were fluorescently labeled with Cy5 and incubated with CT26 colon carcinoma spheroids. Confocal laser scanning microscopy taken after 2 hours of incubation (Fig. 3) show that NPs with both comb lengths can penetrate effectively into the spheroids, with significant fluorescence observable at least 60 μm into the spheroids. The effectiveness of DOX-loaded P(L)LA10K-b-POEGMA10K NPs in killing these spheroids was then assessed via LIVE/DEAD staining, comparing to non-drug loaded spheroid controls (Fig. 4A). Even in control (untreated) spheroids, a significant amount of dead cells is observed consistent with the necrotic cores of in vivo tumors; however, treatment with any DOX-loaded nanoparticle shows increased red fluorescence compared to control spheroids. Comparing the live:
dead ratio (calculated by dividing green fluorescence by red fluorescence in each treatment group in triplicate, Fig. 4B), control spheroids had ∼1
:
1 live/dead cells, while higher ratios of dead cells were seen in P(L)LA10K-b-PEG10K (0.72 ± 0.06), P(L)LA10K-b-POEGMA47510K (0.58 ± 0.05), and P(L)LA10K-b-POEGMA200010K (0.59 ± 0.08). Interestingly, while the DOX-loaded linear–linear copolymer P(L)LA10K-b-PEG10K did not induce a significantly lower live
:
dead ratio compared to the control, both P(L)LA10K-b-POEGMA10K formulations did; we attribute this result to the high penetration capacity of the P(L)LA10K-b-POEGMA10K formulations. Fig. 4A also shows increased dead cells at deeper regions of the spheroid (60 μm) for both P(L)LA10K-b-POEGMA47510K and P(L)LA10K-b-POEGMA200010K compared to P(L)LA10K-b-PEG10K as well as a thin veil of dead cells at all penetration depths, likely indicative of dead cancer cells breaking from the surface of the spheroid. As such, the linear-comb P(L)LA10K-b-POEGMA47510K and P(L)LA10K-b-POEGMA200010K NPs can both penetrate deep into tumor cells and efficiently release DOX to enhance spheroid toxicity compared to that observed with the linear–linear P(L)LA10K-b-PEG10K NPs.
![]() | ||
Fig. 3 Penetration of Cy5-labeled P(L)LA10k-b-POEGMA47510k and P(L)LA10k-b-POEGMA200010k into CT26 tumor spheroids. |
To assess the differences in biodistribution achieved according to the different sizes and colloidal stabilities of NPs formed from linear–linear versus linear-comb block copolymers, Cy5-labeled NPs were injected in the tail vein of mice and the biodistribution of the fluorescently labeled NPs was tracked using both ex vivo imaging as well as fluorescence quantification of homogenized tissue samples. Cy5 was incorporated in sufficient quantities to maximize signal but to minimize any interfacial changes in the nanoparticles that may impact cell–nanoparticle interactions (<5 mol% total monomer residues functionalized), consistent with or lower than approaches used in other studies.39,40Fig. 5 shows the ex vivo IVIS images of each organ excised after 2 h, 8 h, and 24 h post-administration (refer to ESI, Fig. S8† for the corresponding measured irradiance values). P(L)LA10K-b-PEG10K showed high fluorescence in all organs and the tumor (right-most column) even at the very short 2 hour time point that does not significantly change over the subsequent 22 hours, indicating relatively rapid deposition of the linear–linear NPs in organs; note that the Cy5 density is higher on the commercial linear–linear block copolymer than on the internally-synthesized linear-comb copolymers, such that absolute fluorescence values cannot be compared between the different samples but can be compared within single samples at different timepoints. Conversely, a relatively lower fluorescence signal was noted for both linear-comb copolymers at 2 h but continuing accumulation of the NPs (particularly in the tumour) was observed over the full 24 hour period of the circulation time experiment.
Homogenization of the organs to facilitate improved quantification of the fluorescence single yielded a similar trend (Fig. 6), with the linear–linear P(L)LA10K-b-PEG10K copolymer showing significant tumor accumulation at short times but little if any additional accumulation over the subsequent 22 hours (Fig. 6A) while significant increases in tumor fluorescence (both in absolute terms as well as in relative terms to the off-target organs) were observed for both comb copolymer-based NPs (Fig. 6B and C) over the full 24 hour period of the circulation time test. Furthermore, at 24 h, a significantly larger percentage of the total fluorescent signal (Fig. S9†) was observed from the tumor tissue with P(L)LA10K-b-POEGMA47510K (34.2 ± 0.5%) and P(L)LA10K-b-POEGMA200010K (28.5 ± 2.8%) relative to the linear P(L)LA10K-b-PEG10K control (19.0 ± 2.1%) (p < 0.05 in both pair-wise comparison), suggesting improved overall accumulation of the NPs in the tumor with the comb copolymers.
NPs fabricated from linear-comb copolymers of comparable length were significantly smaller than those fabricated using their linear–linear counterparts. PEG comb copolymers have been reported to present a more sterically stable interface due to the high density of PEG repeat units covalently tethered in close proximity within the comb structure, enabling the stabilization of more surface area (i.e. smaller particle sizes).41 When prepared in THF, PEG10K-b-P(L)LA10K demonstrated a significant change in size over a 15 day period of incubation at 37 °C whereas neither P(L)LA10K-b-POEGMA47510K nor P(L)LA10K-b-POEGMA200010K showed significant changes in particle size over the same time period; similarly, when the NPs were prepared in DMF, the POEGMA475 linear-comb copolymer-based NPs exhibited good particle size stability while the linear–linear copolymer-based NPs showed very high size increases. These observations both also support the higher degree of steric stabilization facilitated by the comb structure in the hydrophilic block.41 However, the linear-comb block copolymers facilitated lower drug loading than the linear–linear block copolymers, with the longer chain P(L)LA10K-b-POEGMA200010K block copolymer showing a particularly reduced drug loading. In this context, we hypothesize that the same high comb density that enables improved colloidal stability also hinders the tight packing of the P(L)LA domains to reduce the size and/or packing density of the P(L)LA domains within the self-assembled NPs, leading to a reduced affinity and/or volume within the nanoparticle for hydrophobic drug loading. As such, depending on the dose required of a specific drug, the lower sizes and higher colloidal stability of the linear-comb block copolymers may be most relevant to apply with more potent drugs that require lower functional doses to be effective, with the shorter side chain POEGMA475-based NPs offering an appealing balance of both high colloidal stability and still relatively high drug loading. However, both POEGMA-based linear-comb block copolymers tested can enable both highly effective penetration into spheroids (attributed to the dense hydrophilic interface, higher nanoparticle stability, and smaller nanoparticle sizes enabled by the comb POEGMA polymer) as well as more efficient tumor killing, even compared to the PEG-based linear copolymer analogue that enables enhanced DOX loading. Indeed, the observation that the POEGMA-based NPs facilitate improved anti-tumor activity despite having lower drug loading capacities shows the importance of the PEG architecture in facilitating tumor transport, with shorter main chains and longer/denser PEG comb lengths enabling improved transport into tumors and thus improved tumor killing.
In vivo biodistribution experiments demonstrated significant accumulation of all NPs in tumors (Fig. 5 and 6); however, comb NPs displayed increased accumulation over a 24 hour time period and continuous localization of the NPs in the tumor over the full 24 hour test window. Specifically, P(L)LA10K-b-POEGMA47510K displayed a spike in NP concentration between the 8 and 24 hour timepoints whereas P(L)LA10K-b-POEGMA200010K displayed showed continuous increases over all timepoints, in contrast to P(L)LA10K-b-PEG10K which did not show any significant enhancement in tumor localization over the time period of the test. Furthermore, the spleen was the only other organ to show significant NP accumulation over time, specifically in the case of P(L)LA10K-b-POEGMA47510K NPs (although the accumulation is relatively low over the tested time window). Taken together, we interpret these results as the linear-comb block copolymers facilitating prolonged circulation times and thus continual accumulation in the tumor relative to the linear–linear block copolymer. While the precise mechanism leading to this result would require further study (i.e. if PEG antibody interactions are indeed suppressed by using POEGMA or if the brush structure otherwise alters the interfacial hydration layer to suppress more general opsonization), these results suggest potential advantages of the linear-comb copolymers for passive tumor drug targeting that can reduce the risk of off-target effects that are strongly detrimental to the safety and efficacy of anti-cancer therapies.
Footnote |
† Electronic supplementary information (ESI) available. See DOI: https://doi.org/10.1039/d3na01156a |
This journal is © The Royal Society of Chemistry 2024 |